By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Juvenile Diabetes Research Foundation 

26 Broadway
14th Floor
New York  New York  10004  U.S.A.
Phone: 212-479-7571 or 800-533-CURE Fax: n/a


Company News
Capillary Biomedical Developing Improved Insulin Delivery Catheter With Funding Support From Juvenile Diabetes Research Foundation 8/3/2016 11:03:35 AM
Infant Colds, Infections And Type 1 Diabetes Risk, Juvenile Diabetes Research Foundation Study 5/5/2016 6:57:25 AM
Juvenile Diabetes Research Foundation And American Diabetes Association, In Collaboration With Multiple Diabetes Organizations Publish New Classification And Staging Approach For Presymptomatic Type 1 9/25/2015 11:48:59 AM
REGiMMUNE Announces Collaboration With Juvenile Diabetes Research Foundation And Pfizer (PFE) For Type 1 Diabetes Prevention And Treatment Promoting Regulatory T-Cells 4/14/2015 11:25:43 AM
Juvenile Diabetes Research Foundation To Ring The Nasdaq Stock Market Closing Bell 2/16/2015 8:56:00 AM
Juvenile Diabetes Research Foundation-Funded Islet Encapsulation Program Reaches Historic Milestone 10/29/2014 8:36:20 AM
Selecta Biosciences, Inc., Juvenile Diabetes Research Foundation And Sanofi (SAN.PA) Extend Collaboration To Develop A Synthetic Vaccine Particle Immunotherapy For Type 1 Diabetes 10/15/2014 9:41:07 AM
Juvenile Diabetes Research Foundation Partner ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Key Project Milestone To Advance Innovative Encapsulated Cell Replacement Therapy Product For Type 1 Diabetes 7/17/2014 11:01:59 AM
Lexicon Pharmaceuticals, Inc. (LXRX) And Juvenile Diabetes Research Foundation Collaborate For Phase 2 Clinical Trial Of LX4211 In Type 1 Diabetes 7/9/2014 9:25:05 AM
Juvenile Diabetes Research FoundationTeams Up With Pfizer Inc. (PFE)'s Centers for Therapeutic Innovation to Support Novel Translational Research in Type 1 Diabetes 11/4/2013 9:33:07 AM